DOI: 10.25345/c58s7k
title: MassIVE MSV000080637 - MaHPIC Experiment 23: Lipidomics from Macaca mulatta infected with Plasmodium cynomolgi B strain to produce and integrate clinical, hematological, parasitological, and omics measures of acute primary infection and relapses.
title: &lt;p&gt;Malaria-naive male rhesus macaques (&lt;i&gt;Macaca mulatta&lt;/i&gt;), approximately four years of age, were inoculated intravenously with salivary gland sporozoites produced and isolated at the Centers for Disease Control and Prevention from multiple &lt;i&gt;Anopheles&lt;/i&gt; species (&lt;i&gt;An. dirus&lt;/i&gt;, &lt;i&gt;An. gambiae&lt;/i&gt;, and &lt;i&gt;An. stephensi&lt;/i&gt;) and then profiled for clinical, hematological, parasitological, immunological, functional genomic, lipidomic, proteomic, and metabolomic measurements. The experiment was designed for about 100 days, with pre- and post-100 day periods to prepare subjects and administer curative treatments respectively. During the 100-day period subjects experienced periods of patent and sub-patent infection. The anti-malarial drug artemether was subcuratively administered to subjects after the initial peak of infection, if subjects were not able to self-resolve. Blood-stage curative artemether was administered to all subjects following peak infection, and following a period of relapse infection. All peaks were clinically determined for each subject. The anti-malarial drugs primaquine and chloroquine were administered to all subjects at the end of the study for curative treatment of the liver and blood-stage infections, respectively. Capillary blood samples were collected daily for the measurement of CBCs, reticulocytes, and parasitemias. Capillary blood samples were collected every other day to obtain plasma for metabolomic analysis. Venous blood and bone marrow samples were collected at seven time points for functional genomic, proteomic, lipidomic, and immunological analyses. Within the MaHPIC, this project is known as 'Experiment 23' ('E23'). To access other publicly available results from E23 and other MaHPIC Experiments, including clinical results (specifics on drugs administered, diet, and veterinary interventions), and other omics, visit &lt;a href="http://plasmodb.org/plasmo/mahpic.jsp"&gt;http://plasmodb.org/plasmo/mahpic.jsp&lt;/a&gt;.  This is an iteration of Experiment 04 with the same parasite-host combination and sampling and treatment adjustments made, and this is the first in a series of experiments that includes subsequent homologous (Experiment 24, &lt;i&gt;P. cynomolgi&lt;/i&gt; B strain) and heterologous (Experiment 25, &lt;i&gt;P. cynomolgi&lt;/i&gt; strain ceylonensis) challenges of individuals from the Experiment 23 cohort.  One subject was not included in subsequent experiments due to persistent behavioral issues that prevented sample collection. This dataset was produced by: The MaHPIC Consortium, Monica Cabrera, Jeremy D. DeBarry, Mary G. Galinski, Jay Humphrey, Ebru Karpuzoglu, Jessica C. Kissinger, Regina Joice, Esmeralda Meyer, Alberto Moreno, Mustafa Nural, Dan Ory, Suman Pakala, and Xuntian Jiang.  The experimental design and protocols for this study were approved by the Emory University Institutional Animal Care and Use Committee (IACUC).&lt;/p&gt;
&lt;p&gt;
For more information on the MaHPIC, please visit &lt;a href="http://www.systemsbiology.emory.edu/"&gt;http://www.systemsbiology.emory.edu/&lt;/a&gt;.
Within the MaHPIC, these data were collected as part of 'Experiment 23' ('E23'). To access other publicly available results from 'E23' and other MaHPIC Experiments, including clinical results (specifics on drugs administered, diet, and veterinary interventions), and other omics, visit &lt;a href="http://plasmodb.org/plasmo/mahpic.jsp"&gt;http://plasmodb.org/plasmo/mahpic.jsp&lt;/a&gt;.  This page will be updated as datasets are released to the public.&lt;/p&gt;